Trial | NCT00307996  Report issue

Title

The Effect of CoQ10 Administration on Hemodialysis Patients
The Effect of CoQ10 Administration on the Oxidative and Antioxidative Markers in Hemodialysis Patients

  • Phase

    Phase 4

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Intervention/Treatment

    ubiquinone ...

  • Study Participants

    40
The purpose of this study is to examine whether CoQ10 administration is effective as an antioxidant in hemodialysis patients.
Oxidative stress has been recognized as a potential risk factor for such complications as atherosclerosis in hemodialysis patients. This study investigates whether CoQ10 administration is effective for protecting oxidative stress in hemodialysis patients. The subjects were recruited from day-time hemodialysis patients in Iwata City Hospital. 100 mg CoQ10 was administered every HD for 6 months. Several oxidative and antioxidative markers were measured in plasma at pre, 1, 3, 6 months and after washout.
Study Started
Mar 31
2004
Study Completion
Dec 31
2004
Last Update
Mar 28
2006
Estimate

Drug Coenzyme Q10 (drug)

Criteria 

Inclusion Criteria:

hemodialysis for at least 6 months

Exclusion Criteria:

none
No Results Posted